Document › Details
Bruker Corporation. (4/6/16). "Press Release: The Weizmann Institute of Science Selects Bruker GigaHertz NMR Technology to Enable Advanced Structural Biology Research". Rehovot & Billerica, MA.
|Organisation||Bruker BioSpin (Operating Business of Bruker Corporation)|
|Group||Bruker Corporation (Group)|
|Organisation 2||Weizmann Institute of Science|
|Product 2||structural biology|
|Person||Haran, Gilad (Weizmann Institute 201604 Prof + Dean of Faculty of Chemistry)|
|Person 2||Maas, Werner (Bruker 201104 President Bruker BioSpin)|
Weizmann Makes Major Investment in Magnetic Resonance Research Infrastructure with 1 GHz NMR, DNP-NMR and 15 Tesla Preclinical MRI System to Further Accelerate World-Class Research
The Weizmann Institute of Science in Rehovot, Israel today announced major scientific instrument purchases from Bruker (NASDAQ: BRKR), including a novel Aeon™ 1GHz nuclear magnetic resonance (NMR) system for expanding frontiers in structural biology and intrinsically disordered protein (IDPs) research. Furthermore, the Weizmann Institute is adding an Aeon 600 MHz NMR, a 263 GHz dynamic nuclear polarization (DNP)-NMR system, and a Biospec® 15 Tesla system for preclinical ultra-high field magnetic resonance imaging (MRI). Various NMR and electron paramagnetic resonance (EPR) instrument upgrades round out this major acquisition, instantly propelling the Weizmann Institute to the frontiers of modern magnetic resonance research infrastructure.
In the 1950s, one of the world's first high resolution NMR systems was conceived at Weizmann Institute researchers Alexander and Meiboom, and since then three generations of renowned Weizmann magnetic resonance researchers have played key roles in the development of NMR, EPR and MRI. Going forward, the focus of the Weizmann Institute in magnetic resonance research will be on biomolecular NMR and EPR research for future healthcare applications, metabolomics and preclinical research for cancer diagnostics and neurodegenerative diseases, as well as on advanced research on batteries and advanced materials.
Professor Gilad Haran, Dean of the Faculty of Chemistry at the Weizmann Institute of Science, commented: "In the last 2 years we hired 4 new faculty members specializing in the various branches of MR research. The new instruments will facilitate the research of this world-class group and of their more veteran peers, and will reinforce Weizmann's position as one of the premier centers in the world for MR research."
Werner Maas, Ph.D., the President of the Bruker BioSpin Magnetic Resonance Spectroscopy Division, added: "The adoption of the Aeon 1 GHz NMR platform by the Weizmann Institute further validates this revolutionary technology and its impact on the research of structural biology and intrinsically disordered proteins. We are extremely pleased to partner with the Weizmann Institute and provide the research tools they need to advance scientific understanding of the bio-molecular processes of many diseases affecting people across the globe, as well as the understanding of advanced materials that will impact many emerging technologies."
The Aeon 1 GHz system incorporates the world's first shielded 1 GHz NMR magnet, as well as active refrigeration. Active shielding reduces the space volume occupied by the 5 Gauss stray field of this two-story magnet by more than one order of magnitude, and makes siting of next-generation Aeon 1 GHz magnets straight-forward. The Aeon magnet series features integrated active refrigeration technology, which eliminates the need for liquid nitrogen, and brings liquid helium boil-off essentially to zero in normal operation. Bi-annual pulse-tube cooler maintenance can be done at field with minimal disruption and down-time.
The 263 GHz DNP-NMR spectrometer takes advantage of the dramatic sensitivity enhancements enabled by Dynamic Nuclear Polarization (DNP). The system consists of an Avance™ III HD spectrometer, configured for solid-state NMR, combined with a high-power gyrotron microwave source and a specialized low-temperature DNP/NMR probe in an easy to use, integrated package.
The BioSpec® 150/11 is an ultra-high field MRI scanner for preclinical research on mice that will open new frontiers in molecular and microscopic imaging. Based on Bruker's proven 15 Tesla horizontal USR™ magnet technology, the system takes advantage of the high signal-to-noise ratio and enhanced contrast mechanisms at high field strength. Exploiting the novel 15 Tesla MRI CryoProbe™, the system enables new research on in vivo molecular events in cells.
About The Weizmann Institute of Science
The Weizmann Institute of Science is one of the world's leading multidisciplinary research institutions. The driving force and spirit that inspired its scientific activities was Dr. Chaim Weizmann, a world-renowned chemist who headed the World Zionist Movement for many years and served as the first president of the State of Israel.
Over the years, the Weizmann Institute has grown with the country and been the source of a number of Israeli milestones. These range from pioneering work in cancer research to building the county's first electronic computer and the first particle accelerator.
Other Institute firsts include the development and production of Israel's first ethical (original) drug, new computer languages, the solving of the three-dimensional structures of biological molecules involved in health and disease, and many more. The fields range from optics to genetics, from organ transplants from embryonic tissue to the creation of a nano-biological computer.
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
Photo - http://photos.prnewswire.com/prnh/20160405/351695
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-weizmann-institute-of-science-selects-bruker-gigahertz-nmr-technology-to-enable-advanced-structural-biology-research-300246836.html
SOURCE Bruker Corporation
Yivsam Azgad, Institute Spokesman, Institute Curator, Director, Department of Media Relations, T: 972 (0)8 934 3856, E: firstname.lastname@example.org;
Thorsten Thiel, Ph.D, Director of Marketing Communications, Bruker Corporation, T: 49 (721) 5161-6500, E: email@example.com;
Joshua Young, Vice President, IR & Corporate Development, Bruker Corporation, T: 1 (978)-663-3660, ext. 1479, E: firstname.lastname@example.org
Record changed: 2017-01-06
More documents for Bruker Corporation (Group)
-  Bruker Corporation. (3/29/17). "Press Release: Signaling Continued Investment in China, Bruker Open Beijing Center of Excellence". Beijing....
-  Bruker Corporation. (3/27/17). "Press Release: Bruker Introduces Novel NMR Solutions at ENC 2017". Asilomar, CA....
-  Bruker Corporation. (3/27/17). "Press Release: Bruker Introduces the AVANCE NEO NMR Research Platform at ENC 2017". Asilomar, CA....
-  Bruker Corporation. (3/14/17). "Press Release: Data-safe Process & Quality Control of APIs and Inorganic Impurities with Bruker´s EDXRF Spectrometer S2 PUMA"....
-  Bruker Corporation. (3/6/17). "Press Release: Bruker Introduces New Scientific Instruments and Analytical Solutions at Pittcon 2017". Chicago, IL....
-  Bruker Corporation. (3/3/17). "Press Release: Alcami Invests in Bruker’s D8 Discover HTS System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development". Weert & Karlsruhe....
-  Bruker Corporation. (2/27/17). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA....
-  Bruker Corporation. (2/21/17). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA....
-  University of Warwick. (2/17/17). "Press Release: Molecular Phenomenon Discovered by Advanced NMR Facility"....
-  Bruker Corporation. (2/13/17). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results". Billerica, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]